These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11835913)

  • 1. Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Am J Cardiol; 2002 Feb; 89(4):372-6. PubMed ID: 11835913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
    Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
    Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting.
    Aggarwal A; Schneider DJ; Sobel BE; Dauerman HL
    Am J Cardiol; 2003 Oct; 92(8):924-9. PubMed ID: 14556867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):341-5. PubMed ID: 12112886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention.
    Yildirir A; Acikel S; Ertan C; Aydinalp A; Ozin B; Muderrisoglu H
    Acta Cardiol; 2008 Feb; 63(1):47-52. PubMed ID: 18372580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.
    Rahel BM; Visseren FL; Suttorp MJ; Plokker TH; Kelder JC; de Jongh BM; Bouter KP; Diepersloot RJ
    Cardiovasc Res; 2003 Oct; 60(1):136-40. PubMed ID: 14522415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
    Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
    Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention.
    Kardys I; Oemrawsingh RM; Kay IP; Jones GT; McCormick SP; Daemen J; Van Geuns RJ; Boersma E; Van Domburg RT; Serruys PW
    Clin Cardiol; 2012 Aug; 35(8):482-9. PubMed ID: 22488248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D
    Int Heart J; 2005 Mar; 46(2):195-204. PubMed ID: 15876803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
    Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
    Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
    Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
    Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
    Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome.
    Marzocchi A; Ortolani P; Piovaccari G; Marrozzini C; Nobile G; Palmerini T; Marinucci L; Saia F; Bacchi Reggiani ML; Branzi A; Magnani B
    Coron Artery Dis; 1999; 10(2):81-8. PubMed ID: 10219513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty.
    Fracassi F; Niccoli G; Scalone G; Di Gioia G; Conte M; Bartunek J; Sgueglia GA; De Bruyne B; Montone RA; Wijns W; Crea F; Barbato E
    J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):687-93. PubMed ID: 26627500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
    Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC
    Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.